can you explain why Bacillus anthracis can be pathogenic in a mouse and not be fought off by the immune system?
I need help finding the answer in the article and explain in short answer
link to article: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC106848/
Transcribed Image Text: VOL. 180, 1998
94
67
43
30-
20-
1 2 3 4 5 6 7 8
FIG. 6. In vivo expression of the two B. anthracis S-layer components. Im-
munoblotting of pellet fractions (odd-numbered lanes) and supernatant fractions
(even-numbered lanes) of S-layers from wild-type (CAF10) (lanes 1 and 2), Asap
(CBA91) (lanes 3 and 4), Aeag (CSM91) (lanes 5 and 6), and Aeag Asap (CSM11)
(lanes 7 and 8) strains was carried out with pooled sera from mice infected with
the CAF10 strain. Molecular masses are indicated in kilodaltons on the left.
shown). EA1 and Sap were found to be major surface antigens,
showing that both EA1 and Sap can be synthesized by a cap-
sulated strain in vivo.
DISCUSSION
Although various bacteria from natural environments pos-
sess both a capsule and an S-layer, their cosynthesis or struc-
tural relationship has rarely been studied (15).
B. anthracis has a rather unusual capsule: it is composed not
of polysaccharide but of poly-y-D-glutamic acid (13). This bac-
terium also has an S-layer, previously evidenced only in cap-
sule-free strains (10, 16). Another gram-positive bacterium, B.
licheniformis, apparently shares these features, namely, a poly-
y-D-glutamic acid capsule and an S-layer (9, 33). However, this
B. licheniformis strain, in which the S-layer component is very
similar to EA1 (20), seems to lack a capsule. We therefore
investigated whether these two structures, the capsule and the
S-layer, were exclusive. We found that B. anthracis bacilli syn-
thesize EA1, Sap, and the capsule both in vivo and in vitro.
Furthermore, the capsule and a structured S-layer were found
to be simultaneously present on the bacterial surface, the cap-
sule covering the S-layer. Thus, B. anthracis displays a highly
complex ultrastructural cell wall architecture.
The coexistence of the capsule and the S-layer could have
indicated a structural dependence. Such was not the case, as
the S-layer was found in noncapsulated strains and the capsule
was present on the EA1-Sap double deletion mutant. These
results further suggest that the capsule is anchored either to
the peptidoglycan-containing sacculus or to the cytoplasmic
membrane, independently of the S-layer. However, the fine
structure of the capsule may depend on the presence of the
underlying S-layer: the S-layer may modify the arborescence of
the poly-y-D-glutamic acid fibers. That these structures can be
independently synthesized and formed does not exclude func-
tional interactions.
Pathogenic organisms have various strategies to escape host
recognition. One such strategy, which is widespread, is anti-
genic variation of exposed proteins, including S-layer proteins.
For example, in Campylobacter fetus, genetic rearrangements
enable the bacterium to change S-layer components (2, 5). The
variants can therefore multiply before the antibody response
has developed against the new protein. No gene rearrange-
ment between the B. anthracis S-layer genes has been observed
(data not shown). The absence of immunolabeling on B. an-
thracis whole cells (Fig. 4B and D) in the presence of the
capsule suggests that the cell surface is inaccessible to antibod
BACILLUS ANTHRACIS CAPSULE AND S-LAYER 57
ies. The presence of anti-EA1 and anti-Sap antibodies in the
sera of mice inoculated with strain CAF10 (Fig. 6) indicates
that these proteins are synthesized in vivo by the capsulated
strain. The presence of these antibodies could be due to the
synthesis of these proteins prior to the complete coverage of
the surface by the capsule or to leakage or bacterial lysis.
Interestingly, the capsule seems to function as a "one-way"
filter. EA1 and Sap are not accessible to antibodies from the
outside, whereas the three toxin components (protective anti-
gen, lethal factor, and edema factor) and Sap are found in
culture supernatants of capsulated strains, suggesting that they
diffuse from the cell through the capsule to the extracellular
medium.
The S-layer may have a protective role in the absence of the
capsule. It could also be a molecular sieve or could have a still
more structural role, delimiting the periplasm, as recently de-
scribed for gram-positive bacteria (1, 11).
ACKNOWLEDGMENTS
We are grateful to A. L. Sonenshein for critical reading of the
manuscript. We thank B. Chavinier-Jove and C. Rolin for excellent
technical assistance with electron microscopy experiments and photo-
graphic prints, respectively.
S.M. was supported by the Ministère de l'Enseignement Supérieur
et de la Recherche.
REFERENCES
1. Beveridge, T. J. 1995. The periplasmic space and the periplasm in gram-
positive and gram-negative bacteria. ASM News 61:125-130.
2. Blaser, M. J., E. Wang, M. K. R. Tummuru, R. Washburn, S. Fujimoto, and
A. Labigne. 1994. High frequency S-layer protein variation in Campylobacter
fetus revealed by sapA mutagenesis. Mol. Microbiol. 14:521-532.
Jonas Jon
3. Carlemalm, E., R. M. Garavito, and W. Villiger. 1982. Resin development
for electron microscopy and an analysis of embedding at low temperature. J.
Microsc. 126:123.
4. Duguid, J. P. 1951. The demonstration of bacterial capsules and slime.
J. Pathol. Bacteriol. 63:673-685.
5. Dworkin, J., and M. J. Blaser. 1997. Nested DNA inversion as a paradigm of
programmed gene rearrangement. Proc. Natl. Acad. Sci. USA 94:985-990.
6. Etienne-Toumelin, I., J.-C. Sirard, E. Duflot, M. Mock, and A. Fouet. 1995.
Characterization of the Bacillus anthracis S-layer: cloning and sequencing of
the structural gene. J. Bacteriol. 177:614-620.
7. Farchaus, J. W., W. J. Ribot, M. B. Downs, and J. W. Ezzell. 1995. Purifi-
cation and characterization of the major surface array protein from the
avirulent Bacillus anthracis Delta Sterne-1. J. Bacteriol. 177:2481-2489.
8. Fouet, A., and M. Mock. 1996. Differential influence of the two Bacillus
anthracis plasmids on regulation of virulence gene expression. Infect. Im-
mun. 64:4928-4932.
9. Gardner, J. M., and F. A. Troy. 1979. Chemistry and biosynthesis of the poly
(y-D-glutamyl) capsule in Bacillus licheniformis. Activation, racemization,
and polymerization of glutamic acid by a membranous polyglutamyl syn-
thetase complex. J. Biol. Chem. 254:6262-6269.
10. Gerhardt, P. 1967. Cytology of Bacillus anthracis. Fed. Proc. 26:1504-1517.
11. Graham, L. L., T. J. Beveridge, and N. Nanninga. 1991. Periplasmic space
and the concept of periplasm. Trends Biochem. Sci. 16:328-329.
12. Green, B. D., L. Battisti, T. M. Koehler, C. B. Thorne, and B. E. Ivins. 1985.
Demonstration of a capsule plasmid in Bacillus anthracis. Infect. Immun.
49:291-297.
T
13. Hanby, W. E., and H. N. Rydon. 1946. The capsular substance of Bacillus
anthracis. Biochem. J. 40:297-309.
tra
14. Hayat, M. A. 1981. Fixation for electron microscopy, p. 110-111. Academic
Press, Inc., New York, N.Y.
ress,
15. Hoiczyk, E., and W. Baumeister. 1995. Envelope structure of four gliding
filamentous cyanobacteria. J. Bacteriol. 177:2387-2395.
mant
16. Holt, S. C., and E. R. Leadbetter. 1969. Comparative ultrastructure of se-
lected aerobic spore-forming bacteria: a freeze-etching study. Bacteriol. Rev.
33:346-378.
17. Karnovsky, M. J. 1965. A formaldehyde-glutaraldehyde fixative of high os-
molarity for use in electron microscopy. J. Cell Biol. 27:137A.
18. Keppie, J., H. Smith, and P. W. Harris-Smith. 1953. The chemical basis of
the virulence of Bacillus anthracis. II. Some biological properties of bacterial
products. Br. J. Exp. Pathol. 34:486-496.
19. Laemmli, U. K. 1970. Cleavage of structural proteins during the assembly of
the head of bacteriophage T4. Nature 227:680-685.
20. Mesnage, S., E. Tosi-Couture, M. Mock, P. Gounon, and A. Fouet. 1997.
Molecular characterization of the Bacillus anthracis main S-laver compo
Transcribed Image Text: FIG. 4. Whole-mount noncapsulated (A and C) and capsulated (B and D) CAF10 bacteria immunolabeled with anti-Sap (A and B) and anti-EA1 (C and D)
antibodies. Preparations of cultures were incubated with anti-Sap or anti-EA1 antibodies, and binding was revealed with 10-nm gold-conjugated anti-rabbit antibodies.
Bar, 1 µm.
in conditions inducing capsule synthesis (Fig. 4B and D). La-
beling, such as in Fig. 4B, was infrequently observed in prep-
arations of capsulated cells and presumably corresponded to
the leakage of S-layer components from the bacteria through
the capsule. This result indicated that the capsule is distal to
the S-layer components and that it completely masks access of
the specific antibodies to EA1 and Sap. Capsule and S-layer
components can therefore coexist, and the S-layer proteins are
localized between the peptidoglycan and the capsule.
Analysis of the state of capsulation of strains with a deletion
of S-layer component genes. We determined whether the S-
layer proteins were required for normal capsulation of the
bacteria. Mutants with deletions of the EA1 gene (CSM91),
the Sap gene (CBA91), or both eag and sap (CSM11) were
constructed as previously described (20) (Table 1). The pellet
and supernatant fractions of CAF10 derivatives grown in cap-
sule synthesis-inducing conditions were analyzed by polyacryl-
amide gel electrophoresis and immunoblotting with anti-EA1
and anti-Sap antibodies (data not shown). The results indi-
cated that EA1 and Sap are expressed similarly in the presence
and the absence of the capsule and also that, in both cases, Sap
is shed into the supernatant.
Each strain was grown on CAP plates. The colonies were
smooth, suggesting that a capsule was synthesized. The pres-
ence of the capsule around the bacteria was confirmed by
optical microscopy (Fig. 1A and B). Bacilli from wild-type and
S-layer mutants were all capsulated, and no obvious difference
in the aspect of capsulation could be seen. The capsule was
studied in more detail by electron microscopy (Fig. 3A to D).
The micrographs showed that similar amounts of capsule were
found around all bacteria tested. This result indicated that the
S-layer components, EA1 and Sap, are not required for normal
capsulation of B. anthracis bacilli.
Coexistence of the capsule and of the structured S-layer. We
tested whether EA1 and Sap are organized in a two-dimen-
sional crystalline array when covered by the capsule. Thin
sections (Fig. 3A to C) suggested that the S-layer proteins were
organized in sheaths. The surfaces of strains CAF10 (EA1+
Sap), CBA91 (EA1+), CSM91 (Sap), and CSM11 grown in
capsule synthesis-inducing conditions were further analyzed
for the presence of structured layers by negative staining (Fig.
5). The cells were vortexed in the presence of glass beads (20).
This treatment disrupted the bacteria and tore off the capsule,
thus unmasking the S-layers. As expected, no crystalline array
was present on the surface of CSM11 cells (data not shown).
Conversely, structured layers were clearly visible on CAF10,
CBA91, and CSM91 cells (Fig. 5A, B, and C, respectively).
This result suggested that in the presence of the capsule, the
S-layer components, EA1 and Sap, were able to form struc-
tured surface arrays. However, the lattices on these various
strains appeared different. The EA1 array was more stable
than the Sap array, which was only observed at glutaraldehyde
concentrations higher than those required for EA1. In addi-
tion, this is the first time that a Sap array has been visualized.
Our observations are consistent with the previous suggestion
that Sap forms its own, more fragile, structure (20). They also
show that the S-layer and capsule structures coexist on the
same cell surface.
In vivo production of the capsule and the S-layer. To deter-
mine whether both the capsule and the S-layer could be pro-
duced in vivo, the presence of anti-EA1 and anti-Sap antibod-
ies was tested in sera from mice infected with strain CAF10,
which is capsulated in vivo (Fig. 6). Sera from infected mice
recognized EA1 and Sap but no other bacterial protein under
the conditions used. The specificities of the antibodies were
confirmed with sera adsorbed onto either EA1 or Sap (data not